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Abstract
Ptaquiloside is a natural toxin present in bracken ferns (Pteridium sp.). Cattle ingesting
bracken may develop bladder tumours and excrete genotoxins in meat and milk. However,
the fate of ptaquiloside in cattle and the link between ptaquiloside and cattle carcinogenesis
is unresolved. Here, we present the toxicokinetic profile of ptaquiloside in plasma and urine
after intravenous administration of ptaquiloside and after oral administration of bracken.
Administered intravenously ptaquiloside, revealed a volume of distribution of 1.3 L kg-1 with
a mean residence-time of 4 hours. A large fraction of ptaquiloside was converted to non-
toxic pterosin B in the blood stream. Both ptaquiloside and pterosin B were excreted in urine
(up to 41% of the dose). Oral administration of ptaquiloside via bracken extract or dried
ferns did not result in observations of ptaquiloside in body fluids, indicating deglycosolidation
in the rumen. Pterosin B was detected in both plasma and urine after oral administration.
Hence, transport of carcinogenic ptaquiloside metabolites over the rumen membrane is indi-
cated. Pterosin B recovered from urine counted for 7% of the dose given intravenously. Heif-
ers exposed to bracken for 7 days (2 mg ptaquiloside kg-1) developed preneoplastic lesions
in the urinary bladder most likely caused by genotoxic ptaquiloside metabolites.
Introduction
Ptaquiloside (PTA) is the most well-studied member of the group of highly toxic and geno-
toxic illudane glucosides. The group comprises compounds like caudatoside, ptesculentoside,
and ptaquiloside Z, all glycosides comprising a reactive cyclopropane ringsystem. PTA is pres-
ent in many fern species, including the widespread bracken ferns (Fig 1; [1–4]). Ingestion of
bracken by ruminants is associated with several diseases, including acute haemorrhagic disease
(calves and sheep); bright blindness (sheep); bovine enzootic haematuria (cattle), and upper
alimentary carcinoma (cattle) [5–8].
Bracken is the common name used for the 15 different Pteridium species of which P. aquili-
num (L.) Kuhn is the most abundant taxa in Europe [1,9]. Brackens have world-wide distribu-
tion and are usually found in dense stands inside forests and plantations, at former farmland,
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at heather, in mountains and as natural part of the bush. The ferns are commonly growing at
the edge of paddocks from where they extend belowground rhizomes into the paddocks. Cattle
browse on bracken in times of food scarcity, especially in extensive cattle production systems
where paddocks are unmanaged [9,10]. PTA is widely distributed among the species and can
reach frond concentrations of approx. 40,000 μg/g. In general, the content of PTA is between
500 and 5,000 μg/g. The concentration is variable and generally highest among newly emerged
crosiers [2,3,11–13].
Concerns of Human exposure to PTA have increased during the last decade. Humans may
be exposed to bracken carcinogens by consumption of meat or milk from cattle grazing on
pastures with bracken. Milk from cattle fed bracken has proved mutagenic to Salmonella typhi-
murium TA100 and capable of inducing tumours in rats [15]. Similarly, milk containing PTA
induced the acute haemorrhagic syndrome in calves [16]. PTA has been reported in milk from
cows fed bracken under experimental conditions [17,18], and in milk from animals grazing
bracken [10,19]. In 2011, PTA like-compounds were identified in muscle, liver, kidney and
heart tissue from calves fed bracken [20,21]. Therefore, there are strong indications for the
potential of bracken toxins to reach people via contaminated milk or meat from cattle in
bracken areas. All studies reported above, have used indirect quantification of PTA (derivation
into pterosins, e.g. PTB) since direct analysis of PTA in milk was not possible before 2014 [22].
Today, there is still no direct proof of PTA in milk—only evidence of compounds reacting into
pterosins under different treatments, e.g. PTA but also the metabolites ptaquilosin and the
bracken dienone [22].
PTA is converted to the aglycone ptaquilosin in aqueous solutions upon liberation of glu-
cose and further on to PTB, which is relative stable under laboratory conditions, but rapidly
degrades under influence of microorganisms [23]. The molar ratio between PTA and PTB is
often smaller than 1 as by-products may form depending on the reaction conditions [3]. The
conversion rate is depending on temperature and pH in dilute aqueous solutions. Under alka-
line conditions at room temperature (above pH 9), the aglycone ptaquilosin undergoes aroma-
tization resulting in formation of the highly reactive intermediate compound, the so-called
bracken dienone [14,24]. The dienone is stable in alkaline solutions at room temperature, but
is extremely unstable under acid conditions, being immediately converted to PTB in pure
aqueous solutions [14,25]. The dienone acts as an alkylating agent towards nucleophiles (e.g.
water, alcohols, amines, amino acids, nucleosides and nucleotides) [14,26]. Thus, bracken
fern, PTA, ptaquilosin and the dienone have been related to cytotoxicity [27,28] and genotoxi-
city [29–31] and immunomodulatory effects [32–34]. Under acidic laboratory conditions,
PTA is expected to transform to PTB via ptaquilosin only. However, in complex biological
matrices, such as cattle rumen juice (pH approx. 6.7), plasma (pH approx. 7.4), urine (pH
approx. 8) and milk (pH approx. 6.8) numerous reactions may occur depending on the type of
reactive species present and the interactions caused by hydrolysis, enzymes, temperature,
plants/water eaten together with bracken etc. [35]. The complex in-vivo conditions may result
in deviations from the ideal reaction scheme PTA to PTB with a molar conversion ratio of 1:1
observed under laboratory conditions.
In order to make a proper risk assessment of milk and meat products from cattle living in
bracken infested areas, information on the fate of PTA in the bovine is needed. Currently, no
information is available except from the indirect observations of PTA in meat and milk
referred to above. Accordingly, the aim of the present work was to outline 1) PTA toxicoki-
netics in cattle through intravenous administration of purified PTA and oral administration of
bracken fern, and 2) toxic effects after a short exposure period to the fern.
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Methods and materials
Ptaquiloside, Pteridium aquilinum (bracken fern) extract and dried
bracken fern
Bracken fern pinnae were harvested at Præstø Fed, Denmark (61˚158’N, 69˚72’E) from young
and fully developed ferns at the end of May 2012. The material was dried for 72 hours at 40˚C
and milled to a particle size <2mm. The content of PTA in the dried fern was determined by
extracting 500 mg of milled plant material with 25 mL of Milli-Q water for 60 min. The sample
was centrifuged for 15 min at 3000 g before purification of 4 mL of bracken extract on a Poly-
amide 6 dried packed column (500 mg). The eluate was diluted 3 times and PTA determined
by LC-MS (see below).
Ptaquiloside (CAS no: 87625-62-5; IUPAC name: (2’R,3a’R,4’S,7a’R)-4’-Hydroxy-2’,4’,6’-
trimethyl-3’-oxo-2’,3’,3a’,4’-tetrahydrospiro[cyclopropane-1,5’-inden]-7a’(1’H)-yl β-D-gluco-
pyranoside) was extracted and purified as described by Aranha et al. [22]. The purity of PTA
was determined by quantitative H NMR measuring the proton at C9 of PTA (chemical shift of
5.7 ppm) against an internal standard of 0.5 mM of deuterated trimethylsilyl propanoic acid.
The purity was 95%.
Bracken extract used for oral administration was obtained by water extraction of the milled
dried plant material; 150 g was extracted with 1.5 L of Milli-Q water for 60 min. Afterwards
the extract was passed through cheese cloth and centrifuged for 15 min at 3000 g before
Fig 1. Acid and base catalysed hydrolysis of PTA [14].
https://doi.org/10.1371/journal.pone.0218628.g001
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loading on 2 columns dry packed with 15 g Polyamide 6. The concentration of PTA in the
bracken extract was determined by diluting the solution 3 times with Milli-Q water and deter-
mination by LC-MS (see below). The extracts were kept at 5˚C until use within 48 hours. One
mL of the extract was collected immediately before administration to confirm that PTA
remained intact during storage.
Dried bracken used in the one-week-exposure study was milled and divided in several por-
tions of 59, 70, 58 and 85 g which correspond to a PTA dose of 2.5 μmoles kg-1 of body weight
(bw) (1 mg kg-1). Molasses was acquired from Danish Agro (Karise, Denmark) and 50 to 100 g
was added to each portion of dried fern together with 100 to 150 mL of tap water.
Chemicals, reagents and solid phase extraction cartridges
Polyamide 6 was obtained from Fluka (Steinheim, Switzerland). B-Glucuronidase/Arylsulfatase
from Helix pomatia L. was purchased from Roche (Mannheim, Germany). Oasis HLB SPE car-
tridges were used for sample preparation (Waters, Hedehusene, Denmark). All other chemi-
cals were obtained from commercial sources and were of analytical grade [22].
Animals
Single dose trials. Two healthy Jersey heifers weighing 92 and 98 kg (5 months old) were
obtained from a local dairy farm for single dose studies (no’s 4848 and 4849; Svanholm,
Skibby, Denmark). The heifers had never been exposed to PTA or to bracken fern. They were
kept in individual boxes during the trial periods with bedding consisting of straw and wood
shavings. The heifers were fed with complete feed concentrate (Grønkalv Maxi; DLG Copen-
hagen, Copenhagen, Denmark) twice daily according to nutrition requirements (1.25–2.00 kg
per meal) [36]. Barley straw and water were provided ad libitum.
One week repeated dose trial. The two heifers used for the single dose trials were also
used for the one week repeated dose study together with an additional two Jersey heifers (no’s
1550 and 1567; Harald Hansen Eftf. I/S, Slangerup, Denmark) weighing 163 to 237 kg. The
additional two heifers had never been exposed to PTA or to bracken fern. A wash-out period
of 20 days between the last single-dose experiment and the one week repeated dose trial was
established for heifers no’s 4848 and 4849.
Experimental protocol, in vivo studies
Single dose studies. Two heifers (no’s 4848 and 4849) were used in a series of five experi-
ments (Table 1) in a cross-over design including intravenous administration of pure PTA, oral
administration of bracken extract and oral administration of dried bracken fern. At least 2
weeks elapsed between each experiment.
Intravenous administration of PTA. In Experiment 1 the dose of purified PTA (0.21 mg kg-1
body weight (b.w.) / 0.527 μmoles kg-1) was dissolved in 10 mL of sterile water in a brown glass
vial 1 hour before administration and protected from light. The solution was injected through a
catheter (Cavafix Certo: 45 cm, 16 G; B. Braun Melsungen AG, Melsungen, Germany) placed in
the right jugular vein. Blood samples were collected through another catheter placed in the left
jugular vein. Blood samples were collected in heparinized glass tubes before and at predeter-
mined times (10, 20, 30, 45 min and 1, 2, 4, 6, 8, 12, 21 and 24 hours) after PTA administration.
The blood was centrifuged for 15 min at 3000 g to separate plasma which then was stored imme-
diately at -18˚C until assayed within a week following the method of Aranha et al. [22]. Urine
was collected quantitatively in urinary bags (Ratiomed GmBH, Mu¨nchen, Germany) through a
Foley catheter (Rusch Silasil no 16; Teleflex, Milan, Italy) inserted into the bladder. Samples
were collected before and at predetermined times (1, 2, 4, 6, 8, 12, 20 and 24 hours) after PTA
Fate of ptaquiloside—A bracken fern toxin—In cattle
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administration. Two replicates from each sample were diluted 10 times (0.5 mL: 4.5 mL) with
0.1 M acetic acid, buffered to pH 5 with ammonium acetate and frozen immediately at -18˚C
until assayed within a week following the method of Aranha et al. [22]. In the second intrave-
nous experiment (Experiment 4) the PTA was administered intravenously as in Experiment 1,
although the dose of PTA was lower, 0.092 and 0.056 mg kg-1 b.w (0.23 and 0.14 μmoles kg-1.
for heifer no 4848 and no 4849, respectively. In this experiment, PTA was dissolved in sterile
water immediately before injection.
Oral exposure, bracken extract. Bracken extract was administered orally by gavage in
Experiment 2 (170 and 172 mL) and Experiment 5 (820 and 850 mL), to obtain PTA doses of
0.41 and 2 mg kg-1 b.w (1.025 and 5.000 μmoles kg-1), respectively. Blood and urine samples
were collected up to 48 hours after gavage and samples were processed and stored as described
previously.
Oral exposure, dried bracken fern. In Experiment 3, dried bracken fern was milled to a fine
powder. Immediately before administration, the powder was mixed with water to produce a
slurry (15 g of bracken per 100 mL of water). The slurry was administered orally by gavage
(400 mL and 380 mL) corresponding to a PTA dose of 1.6 mg kg-1 b.w (4 μmoles kg-1). Blood
and urine samples were collected up to 72 hours after gavage and the samples were processed
and stored as described above.
One-week repeated dose trial. All four heifers were fed dried bracken powder (top-
dressed and molasses added). twice a day during a period of 7 days providing a daily PTA dose
of 2 mg kg-1 (5 μmoles kg-1). On Day 8, the heifers no 4848 and no 1567 were additionally fed
in the morning and euthanized 1 hour after using a captive bolt pistol and exsanguination.
The two other heifers (no 4849 and no 1550) were euthanized 15 h after the last dose on Day 7
(Fig 2).
Table 1. Overview of PTA doses used in the five animal experiments.
Experiment number 1 2 3 4 5
Intravenous Oral
extract
Oral
fern
Intravenous Oral
extract
Heifer no 4848 4849 4848 4849 4848 4849 4848 4849 4848 4849
PTA dose mg kg-1 0.21 0.41 1.6 0.092 0.056 2
μmoles kg-1 0.53 1.03 4.02 0.231 0.141 5.02
Weight kg 98 92 108 102 118 112 144 143 159 149
Age months 5.5 6 6.5 8 8.5
https://doi.org/10.1371/journal.pone.0218628.t001
Fig 2. Overview of the exposure study protocol.
https://doi.org/10.1371/journal.pone.0218628.g002
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Blank blood samples were collected before the first dose was given. On Day 1 and Day 7
blood samples were collected after the morning dose at predetermined time points between 1
and 6 h after dosing (1, 2, 3, 5 and 6 hours). On Day 2 to Day 6 blood samples were collected
daily 1 hour after 50% or more of the morning feed had been ingested, since the bracken fern
was not eaten instantly. On Day 8 blood samples were collected just before euthanasia. Blood
samples were processed and stored as described above.
Pathology
Necropsy was performed within 1.5 hours after euthanasia. Following gross examination, tis-
sue samples were collected for histological examination from the following organs: Sternal
bone marrow, heart, rumen, omasum, abomasum, small intestine, liver, kidney, and urinary
bladder. The samples were fixed in 10% neutral buffered formalin for five to seven days, pro-
cessed through graded concentrations of ethanol and xylene and embedded in paraffin. Sec-
tions were cut at 2 to 3 μm for liver, heart, rumen, omasum, abomasum, small intestines,
kidney and urinary bladder and at 3 to 5 μm for bone marrow. Thereafter, sections were
stained with haematoxylin and eosin.
Incubation of bracken extract in rumen liquid, in vitro experiments
Samples of rumen contents were collected from two rumen fistulated Jersey cows. The cows
were fed daily with 6 kg of complete feedingstuff (Danish Ragna Grønmix; Danish Agro, Kar-
ise, Denmark) and 2 kg of hay. Barley straw and water were provided ad libitum. The rumen
liquid fraction was obtained by passing the digest through a 250 μm nylon filter. From each
cow, 150 mL rumen liquid was pre-incubated at 37˚C under CO2 atmosphere for 10 min
before 5 mL of bracken extract was added in order to obtain an initial PTA concentration of
17 μM. PTA stability was assessed by removal of 2.5 mL sample for PTA determination after
incubation for 0, 5, 15, 30, 60 and 120 min at 37 ˚C. The sample was immediately centrifuged
for 3 min at 8,500 g and analysed following the method of Aranha et al. [22]. The pH in rumen
liquid was determined at the beginning and termination of the experiment.
Toxicokinetic analysis
Concentrations of PTA in plasma of individual animals were evaluated by non-compartmental
analysis. Toxicokinetic variables were calculated using standard kinetic equations. The area
under the curve (AUC) and the area under the first moment curve (AUMC) were determined
using combined linear and natural logarithm trapezoidal rules. The terminal elimination rate
was determined using the last three data points of the curve [37].
The effect of PTA exposure to plasma aspartate aminotransferase (AST), plasma glutamate
dehydrogenase (GD), and plasma ornithine carbamoyltransferase (OCT) activity was evalu-
ated using two-way ordinary analysis of variance (ANOVA) using exposure time and animal
as variables (PRISM 6.0; GraphPad Software; San Diego, California, USA). A P value <0.05
was considered significant and indicative for changes in activity.
Analytical conditions and procedures
PTA and PTB were analysed by LC-MS after purification using solid phase extraction (SPE)
columns as reported in Aranha et al. [22]. The limit of quantification of PTA and PTB in
plasma was 3.0 x 10−3 μM and 9.30 x 10−3 μM, respectively. Limit of quantifications in diluted
urine was 13 x 10−3 μM for PTA and 8.28 x 10−3μM for PTB.
Fate of ptaquiloside—A bracken fern toxin—In cattle
PLOS ONE | https://doi.org/10.1371/journal.pone.0218628 June 21, 2019 6 / 18
The presence of glucuronides and sulphates was assessed by incubating 1 ml of buffered
urine samples in 0.1 M acetic acid buffer (pH 5) with or without addition of 100 μl of B-glucu-
ronidase/arylsulfatase at 37˚C for 3 hours on a shaking water bath. Afterwards, an aliquot of
950 μl of each samples were cleaned on the Oasis HLB cartridges and analysed as described for
urine samples [22].
Rumen liquid samples were cleaned on HLB cartridges and processed as plasma samples.
PTA and PTB calibration curves were prepared in ruminal fluid deactivated by boiling for 5
minutes. The recovery of PTA and PTB in ruminal fluid was 74% (± 0.5%) and 80% (± 1.2%),
respectively.
Hepatotoxicity was evaluated by determining the plasma levels of AST (37˚C), GD (25/
26˚C) and OCT (37˚C) using the Sigma-AST Activity Assay Kit (MAK055-1KT), and the
Sigma-Aldrich GD Ammonia assay kit (AA0100), and the method of Tsuchiya et al. [38],
respectively.
Ethics statement
This study was carried out in accordance with the rules and regulations for animal experiments
at the University of Copenhagen according to the requisites established by the Danish Acta of
Animal Experiments and Acta of Veterinarian. At University of Copenhagen, Department of
Experimental Medicine is responsible for the local Animal Care and Use Programme. The
study was licensed by the Danish Animal Experiments Inspectorate (permit ID: 2007/561−-
1434). All possible efforts were done to minimize suffering of the experimental animals. All
animals were euthanized by the end of the experiments using a captive bolt pistol and
exsanguination.
Results
Animal studies
Single dose studies.
Intravenous experiments. The plasma concentration of PTA after intravenous administra-
tion of 0.21 mg kg-1 b.w. (0.527 μmoles kg-1) is shown for each heifer in Fig 3A. The concentra-
tion of PTA decreased rapidly and was below the limit of quantification after 12 hours. The
average of the mean residence time (MRT) and clearance was 3.4 h and 0.39 L h-1 kg-1
(Table 2). The apparent volume of distribution at steady state of PTA (Vss) was 1.3 L kg-1 indi-
cating an extensive distribution of PTA to tissues.
Unexpectedly, the PTA metabolite, PTB, peaked at the first sampling point 10 min after
administration of PTA. The concentration of PTB declined with time approximately at the
same rate as PTA (Fig 3A). Since the aqueous injection solution was prepared approximately 1
hour before administration, it was speculated if a fraction of PTA might have converted to
PTB before injection. Consequently, two additional intravenous experiments were conducted
although with lower doses of PTA. In these experiments. Purified PTA was dissolved in sterile
water immediately before administration in order to ensure that PTA was not hydrolysed to
PTB before injection. As shown in Fig 3B similar concentration profiles for PTA and PTB
occurred in these experiments compared to the initial ones (Experiments 1 and 4). It is noted
that the ratio of AUC PTB to AUC PTA remained at approx. 0.4 for heifer no 4848, but increased
from 0.34 to 0.76 for heifer no 4849. This verifies that PTB was not formed in the PTA solution
for injection, but that conversion takes place in the animal either by hydrolysis in the blood or
by liver metabolism.
Both PTA and PTB were detected in urine (Fig 4). Twelve hours after administration 30%
of the dose was recovered as PTA and 12% as PTB with the majority excreted during the first 4
Fate of ptaquiloside—A bracken fern toxin—In cattle
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hours. The majority of the dose was excreted during the first 4 hours. PTA and PTB were not
conjugated with either glucuronic acid or sulphate.
Oral bracken extract and dried fern experiments. PTA was not detected in plasma when the
toxin was administered orally either as bracken extract or as dried bracken fern (Experiments
2, 3 and 5). However, PTB was detected in the plasma from the first sample from 10 min after
oral administration until 6 or 12 hours after administration (Figs 5 and 6). For both bracken
extract and bracken fern the time to maximum concentration in plasma (Tmax) was achieved
after approximately 1 hour, the maximum concentration (Cmax) as well as AUC are presented
in Table 3. Cmax increased proportionally with increasing dose of PTA in the bracken extract,
while AUC was not linearly correlated with dose. Only PTB was recovered in urine, account-
ing for up to 7% of the dose within 24 hours (Fig 6).
Incubation of bracken extract in rumen liquid. PTA concentration decreased during
incubation with fresh rumen fluid and was detectable in rumen fluid from cow no 1 only
immediately after start, whereas in rumen fluid from cow no 2 PTA could be determined both
at the start and after 5 min (Fig 7). The PTB concentration was 1.35 and 1.62 μM at starting
time and increased steadily during the first 15 min of incubation (Fig 7) reaching 2.7 μM after
120 min. The pH remained constant (6.6) during the incubation. Adding PTA to boiled or
pre-frozen rumen fluid did not reveal any degradation of PTA indicating the importance of
activity of microorganisms or enzymes.
Fig 3. PTA and PTB plasma concentrations over time after intravenous administration of PTA at a dose of: a)
0.527 μmoles kg-1 b.w. for both heifers (Experiment 1); b): 0.231 μmoles kg-1 b.w. to heifer no 4848 and 0.141 μmoles
kg-1 b.w. to heifer 4849 (Experiment 4).
https://doi.org/10.1371/journal.pone.0218628.g003
Table 2. Toxicokinetic parameters of PTA and PTB after intravenous injection of PTA.
Experiment 1 Experiment 2
Heifer no 4848 4849 4848 4849
Dose μmoles kg-1 0.527 0.527 0.231 0.141
PTA λz h-1 0.153 0.115 0.379 0.242
AUC0-1 μmoles L-1 h 1.39 1.35 0.829 0.42
MRT h 2.99 3.84 2.04 2.48
Cl (body) L-1 h-1 kg-1 0.38 0.389 0.283 0.334
Vss L kg-1 1.14 1.49 0.567 0.830
PTB AUC0-1 μmoles L-1 h 0.596 0.654 0.284 0.319
AUC0-1 PTB / AUC0-1 PTA 0.429 0.484 0.343 0.760
λz terminal slope; AUC0-1 area under the curve from 0 to infinitive; MRT mean residence time; Cl (body) body clearance; Vss apparent volume of distribution at
steady-state.
https://doi.org/10.1371/journal.pone.0218628.t002
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One week repeated dose trial. As in single dose studies, PTA was not detected in plasma
after oral administration (Fig 8). PTB was detected in the first plasma sample (1 hour after dos-
ing) on Day 1 and Day 7, where after it declined rapidly approaching the limit of detection at 6
hours (Fig 8). The area under curve from 0 to infinity (AUC 0 -1) and the mean transit time
(MTT) for PTB at Day 1 and Day 7 are shown in Table 4. The mean AUC 0 -1 was equal at
Day 1 and Day 7 showing that PTB was not accumulated in the organism, although heifer
1550 revealed somewhat lower AUC at Day 1 than at Day 7, which is likely related with slow
ingestion of the morning dose at the first day. The average of PTB concentration in plasma
was similar between animals during the trial period as shown in Fig 9.
Clinical examination and liver enzyme activity. Overall, none of the heifers showed clinical
signs of acute or chronic bracken intoxication during the course of experiments. The heifers
did not reveal any signs of illness and the refusal of the morning dose on the second day by
heifer no 1550 might be related to the low palatability of the fern despite the fact that molasses
had been added. No refusal was observed after mixing the bracken doses with complete feed-
ing stuff.
In general, significant differences in enzyme activity was observed between animals for
AST, GD and OCT (two-way ANOVA P-values: 0.0408, <0.0001 and<0.0001 respectively;
Fig 10). A significant increase in AST activity was observed during the course of the experi-
ment (P-value 0.0033) while no effects were observed for GD and OCT activities (P-values:
0.5495 and 0.6295; Fig 10). However, an increase in GD activity was observed for a single ani-
mal but with no significant effect on the general model.
Fig 4. PTA, PTB and total (PTA + PTB) accumulative recovery in urine after intravenous administration of PTA
at different dose levels: Heifer no 4848 0.527 dosed with 0.231 μmoles kg-1 (Experiment 1 and 4); heifer no 4849
0.527 dosed with 0.141 μmoles kg-1 (Experiment 1 and 4).
https://doi.org/10.1371/journal.pone.0218628.g004
Fig 5. Plasma concentrations over time for PTB after oral administration of PTA as bracken extract at doses 1.03
and 5.02 μmoles kg-1 (Extract 1.03 and Extract 5.02), respectively, and as dried bracken fern at dose of 4.02 μmoles
kg-1 (Fern 4.02).
https://doi.org/10.1371/journal.pone.0218628.g005
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Gross pathology
At gross examination, the following lesions were found in the urinary bladder mucosa: oedema
(heifers 1567, 4849, and 1550), focal hyperaemia (heifers 1567 and 4848), and focal small
haemorrhages (heifers 4849 and 1550) (Fig 11). Additionally, heifer 4848 was found to be a
freemartin and the liver of heifer 1567 was swollen and contained multiple white foci with a
diameter of up to 1 mm. No lesions were found in the remaining organs.
Histopathology. In all four heifers, histological examination of liver samples revealed
moderate centrolobular hypertrophy of hepatocytes with finely granular cytoplasm, as well as
biliary and capillary hyperplasia mainly located in the portal areas (Fig 12). Additional findings
in the livers were multifocal pericholangic infiltration with mononuclear cells and neutrophils
(heifers 1567, 4848, and 1550) as well as multifocal portal fibrosis (heifers 1567, 4849, and
1550) and multifocal diminutive accumulations of mononuclear cells and single neutrophils
(heifers 1567, 4849, and 1550). The macroscopic lesions in the liver of heifer 1567 were con-
firmed histologically to be acute, multifocal micro-abscesses.
The urinary bladder samples of all four heifers were characterized by diffuse oedema in the
lamina propria and submucosa (most prominent in heifers 1567 and 4849), capillary hyperpla-
sia with hypertrophic cuboidal endothelium in the lamina propria (most prominent in heifers
1567, 4849, and 1550), and diffuse as well as follicular infiltration of the lamina propria with
Fig 6. Accumulative recovery of the PTB dose excreted in urine after oral administration of PTA as bracken
extract at doses 1.03 and 5.02 μmoles kg-1 (Extract 1.03 and 5.02), respectively, and as dried bracken fern with a
dose of 4.02 μmoles kg-1 (Fern 4.02).
https://doi.org/10.1371/journal.pone.0218628.g006
Table 3. Toxicokinetics parameters for PTB in plasma after oral administration of different doses of PTA.
Experiment 3 Experiment 4 Experiment 5
Bracken extract Bracken extract Dried bracken
Heifer no 4848 4849 4848 4849 4848 4849
PTA dose μmoles kg-1 1.03 5.02 4.02
λz h-1 0.234 0.100 0.382 0.290 0.308 0.28
AUC0-1 μmoles L-1 h 0.177 0.367 0.594 0.657 0.897 0.428
MTT h 3.82 4.55 2.89 3.02 3.29 3.58
Tmax h 2.0 0.5 1.0 0.75 0.5 2.0
Cmax μmoles L-1 0.028 0.043 0.160 0.174 0.182 0.074
λz terminal slope; AUC0-1 area under the curve from 0 to infinitive; MTT mean transit time; Tmax time at maximum concentration; Cmax maximum concentration; F
bioavailability, was calculated by dividing the ratio of AUC0-1 oral by the dose and by ratio total PTA AUC0-1 IV by respective dose.
https://doi.org/10.1371/journal.pone.0218628.t003
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mononuclear cells (follicular cystitis, heifer 4848) (Fig 13). No histopathological changes were
found in the remaining organs.
Discussion
Intravenous administration of purified PTA revealed a modest elimination rate of PTA with a
terminal half-life up to 6 hours and a MRT up to 4 hours. The Vss was approximately 1.3 L kg-
1, indicating an almost equal distribution of PTA throughout the body. The profile was
expected due to the amphiphilic properties of PTA, including a hydrophilic nucleus (glucose)
and the lipophilic aglycone part (illudane skeleton) [39]. A rather large fraction of PTA was
rapidly converted to non-toxic PTB. Usually, metabolites are formed at a rate that leads to an
increase in plasma concentration followed by a decrease, when the formation is less than the
elimination. In the actual case, PTB appeared at a peak concentration in the first blood sample
10 min after administration suggesting an immediate hydrolysis of PTA in the blood. Since
Fig 7. Formation of PTB from PTA in rumen liquid (17 μM) during 120 min at 37 ˚C. PTA was observed up to
approx. 5 min after the experiment began. However, it was not possible to determine the exact concentration due to
fast degradation.
https://doi.org/10.1371/journal.pone.0218628.g007
Fig 8. One-week repeated dose trial. PTB plasma profile at Day 1 and Day 7.
https://doi.org/10.1371/journal.pone.0218628.g008
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PTA is rather unstable in aqueous solutions [24,25], it was speculated if a fraction of PTA
might have been converted to PTB in the injection solution. To exclude this artefact, the intra-
venous studies were repeated under very strict conditions, where PTA was dissolved and
injected intravenously within 2 minutes. The new studies demonstrated peak concentrations
of PTA as well as PTB in the first blood sampling, and confirmed an immediate formation of
PTB within the body after PTA administration.
The excretion of PTA and PTB in urine after intravenous administration was almost com-
plete 8 hours after administration, representing 25–50% of the dose. The remaining parts of
the dose may have transformed to other metabolites including ptaquilosin and dienone. PTA
is very unstable under the alkaline conditions found in ruminants urine, and will degrade into
PTB and other metabolites.
PTA was neither detected in plasma or urine after oral administration of bracken extract or
dried bracken fern. PTB was observed in both single and repeated dose studies, indicating a
degradation of PTA in rumen or a first pass metabolism. In vitro studies with rumen fluid con-
firmed that PTA is lost within few minutes in the rumen. Sterilized (boiled) ruminal fluid did
not degrade PTA reflecting that enzymes and/or microorganisms are critical for PTA degrada-
tion. Besides PTB, other metabolites might have been formed as PTB only amounted for 10%
of the added PTA 5 min after the start of incubation and 16% at the final sampling (120 min).
PTA transformed into the dienone reacts as an electrophile with compounds such as amines,
amino acids, nucleosides and nucleotides (Ojika et al. 1987). The transient peak of PTB
observed in plasma in the one week repeated dose study after the morning dose (Fig 8)
amounted for 10% of the PTA dose which correlated with the findings of the rumen incuba-
tion study. Thus, PTA is degraded very fast in rumen and only PTA metabolites are absorbed.
Fletcher et al. [20] measured PTA in plasma and tissues from calves fed P. esculentum (PTA
dose of 4.5 μmol kg-1 b.w.) for 18 and 24 days and observed that the toxin accumulated within
tissue. However, the authors did not measure PTA directly but transformed PTA to PTB
(hydrolysis) followed by quantification of PTB. The dose of PTA ingested in the studies of
Fletcher et al. [20] was almost identical to the single dose study presented in this paper. How-
ever, the peak concentration of PTB in plasma was 26 times higher suggesting the measured
PTB concentration includes other PTA metabolites converted to PTB (e.g. ptaquilosin and the
dienone). The daily dose used in the present study was also similar to that of Fletcher et al. in
the repeated dose study, although PTB did not accumulate as shown by Fletcher and co-work-
ers [20].
PTA has been found in milk samples 38 h after cows have been fed bracken [17,18]. In a
study, one cow was fed 6 kg of freshly cut bracken daily for 7 days corresponding to a PTA
dose of 540 μmol day-1 (� 1.1μmol kg-1), and PTA was found in milk at the concentration of
Table 4. Area under the curve from 0 to infinitive (AUC0-1) and mean transit time (MTT) on Day 1 and Day 7
on the exposure study.
Day 1 Day 7
AUC0-1 MTT AUC0-1 MTT
Animal μmoles L-1 h h μmoles L-1 h h
4848 0.873 4.6 0.968 3.9
1567 1.248 4.4 1.264 3.6
4849 0.591 3.9 0.558 3.0
1550 0.386 2.3 0.606 3.2
Average 0.774 3.8 0.849 3.4
SD 0.373 1.0 0.332 0.4
https://doi.org/10.1371/journal.pone.0218628.t004
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0.28 μM [17]. In another study, cows were fed bracken at higher doses of PTA (12, 23, 41 and
50 μmol kg-1) for 5 days [18]. At the dose of 23 μmol kg-1, the PTA excreted in milk achieved a
plateau of 50 μM representing 9.6% of the dose. In both studies, PTA was determined indi-
rectly by alkalizing the milk aqueous extracts to form PTB. However, in this procedure PTB
might have originated from ptaquilosin and dienone intermediates rather than PTA directly
or from PtB already present. Our studies indicate that PTA is not absorbed at all and, there-
fore, cannot be expected to be excreted in milk (Figs 7 and 8).
Fig 9. Average of PTB plasma concentrations 1 h after more than 50% of the morning dose has been ingested.
Heifers were fed twice a day for 7 days. On Day 8, heifers no 4848 and 1567 received an additional dose one hour
before sample collection. Plasma samples from heifer no 4849 and no 1550 was collected 15 h after the afternoon dose
at Day 7.
https://doi.org/10.1371/journal.pone.0218628.g009
Fig 10. Enzyme activity in plasma before (Day 0) and during the bracken exposure period (Day 1 to Day 8)
corresponding to a daily PTA dose of 2 mg kg-1. AST, aspartate aminotransferase; GD, glutamate dehydrogenase;
OCT, ornithine carbamoyltransferase (OCT). Enzyme activity trend-lines are inserted for individual animals.
https://doi.org/10.1371/journal.pone.0218628.g010
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The pathological changes in liver and urinary bladder are well documented in cattle with
enzootic haematuria [2,40,41]. All animals developed centrolobular hypertrophy of the hepato-
cytes, while 3 heifers were found to have multifocal portal fibrosis. In parallel, an increased
AST activity was observed, while OCT and GD remained constant (Fig 10). It must however
Fig 11. Mucosal surface of the urinary bladder of heifer no 4848. Seven days of bracken fern ingestion (PTA daily
dose of 5 μmoles kg-1). Hyperaemia and focal haemorrhages were the most prominent findings.
https://doi.org/10.1371/journal.pone.0218628.g011
Fig 12. Liver from heifer no 4849. The centrolobular hepatocytes are hypertrophic, which is reflected by their
increased size and the finely granular appearance of the cytoplasm. Haematoxylin and eosin.
https://doi.org/10.1371/journal.pone.0218628.g012
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be noticed that a single animal exhibited increased GD levels. Change in plasma AST is associ-
ated with acute hepatitis and change in GD and OCT with hepatocellular necrosis [42]. In the
study by Fletcher and co-workers mentioned above the plasma activity of AST, creatine kinase,
GD and GGT were reported to be within reference values and no histological changes were
found in the liver. The enzyme levels in cattle with chronic ingestion of bracken are also vary-
ing between studies [43,44]. The differences may be related to the different composition and
concentration of other compounds present in bracken [20,21].
The presence of oedema and infiltration of mononuclear cells in the bladder tissue has been
described previously in cattle with chronic ingestion of bracken [40,41]. Long-term exposure
of bracken has been associated with chronic cystitis, which is one of the most frequent findings
at slaughter in cattle grazing bracken [40,41]. The inflammation and proliferative changes in
the urinary bladder mucosa can be associated with preneoplastic urinary bladder changes.
These changes might be attributed to reactive PTA-metabolites as ptaquilosin and the dienone,
PTA-like compounds such as caudatoside and ptesculentoside or other toxic compounds pres-
ent in bracken [28,45].
Conclusion
This is the first report of the toxicokinetics and urinary excretion of PTA after intravenous and
oral administration. Furthermore, the related pathological changes in the liver and urinary
bladder are described. PTA is rapidly converted to PTB and eliminated via urine when injected
directly into the blood stream. Under natural conditions when cows are eating bracken, PTA
is quickly hydrolysed in rumen to metabolites including PTB. A seven day exposure to PTA in
a feeding trial with bracken was sufficient to induce liver lesions and pathological changes in
the urinary bladder mucosa, which may be classified as pre-neoplastic. Reactive metabolites of
PTA, other illudane glycosides or other unknown genotoxic substances may be the cause of
Fig 13. Urinary bladder mucosa of heifer 1567. The lamina propria is characterised by diffuse oedema and diffuse
and follicular infiltration with mononuclear cells and neutrophils as well as multifocal proliferation of small blood
vessels. Inset: Hypertrophic, cuboidal endothelial cells within proliferating capillaries in the lamina propria.
Haematoxylin and eosin.
https://doi.org/10.1371/journal.pone.0218628.g013
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these effects. Further studies with labelled compounds as well as detailed studies on the reactiv-
ity of PTA and its metabolites are required to give a full picture of the fate of PTA in cattle.
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